| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 14 |
| 1 | METHOTREXATE | 13 |
| 2 | PREDNISONE | 11 |
| 3 | MYCOPHENOLATE MOFETIL | 10 |
| 4 | PREDNISOLONE | 8 |
| 5 | PREDNISOLONE ORAL | 8 |
| 6 | PREDNISOLONE ORAL SOLUTION | 8 |
| 7 | ETANERCEPT | 6 |
| 8 | TACROLIMUS | 6 |
| 9 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLUNISOLIDE | 1 | 0.0007 |
| 1 | ISATUXIMAB | 2 | 0.0003 |
| 2 | CLINDAMYCIN HYDROCHLORIDE | 1 | 0.0003 |
| 3 | DESMOPRESSIN ACETATE | 1 | 0.0003 |
| 4 | BELATACEPT | 1 | 0.0002 |
| 5 | DASPONE | 1 | 0.0001 |
| 6 | DAPSONE GEL, 5% | 1 | 0.0001 |
| 7 | RIFAMPICIN | 1 | 0.0001 |
| 8 | PIRFENIDONE | 4 | 0.0001 |
| 9 | BLINATUMOMAB | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 23 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 13 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 10 |
| 3 | Platinum-based Drug [EPC] | 9 |
| 4 | HER2/neu Receptor Antagonist [EPC] | 5 |
| 5 | Antirheumatic Agent [EPC] | 4 |
| 6 | Pyridone [EPC] | 4 |
| 7 | Aminosalicylate [EPC] | 3 |
| 8 | Anti-IgE [EPC] | 3 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |
| 1 | Selective T Cell Costimulation Blocker [EPC] | 1 | 0.0002 |
| 2 | Pyridone [EPC] | 4 | 0.0001 |
| 3 | Sulfone [EPC] | 1 | 0.0001 |
| 4 | HER2/neu Receptor Antagonist [EPC] | 5 | 0.0001 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 6 | Recombinant Human Deoxyribonuclease 1 [EPC] | 1 | 0.0001 |
| 7 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 8 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Antimycobacterial [EPC] | 1 | 0.0000 |